The objective of the Fund is to match the capital performance of the UK equity market by tracking the FTSE All-Share Index. We aim to match the performance of the FTSE All-Share Index using the method of full replication. The portfolio will therefore normally consist of all of the shares comprising that index in approximate proportion to their respective weightings and in accordance with any constraints imposed by the regulations of the Financial Services Authority. Where considered appropriate, the ACD is also able to use sampling techniques to achieve the objective of tracking the index.
Name | % Net Assets |
---|---|
HSBC | 6.3% |
Vodafone | 5.3% |
BP | 4.2% |
Royal Dutch Shell | 3.9% |
GlaxoSmithKline | 3.9% |
British American Tobacco | 3.2% |
Royal Dutch Shell | 2.9% |
Diageo | 2.5% |
AstraZeneca | 2.0% |
BG | 2.0% |
Key | % Net Assets |
---|---|
HSBC | 6.3% |
Vodafone | 5.3% |
BP | 4.2% |
Royal Dutch Shell | 3.9% |
Other | 80.3% |
Date | 30-Jun-2017 |
---|---|
NAV | 1,423.81p |
Currency | GBP |
Change | -5.83p |
% | -0.41% |
YTD change | 1,423.81p |
YTD % | n/a |
Fund Inception | 20/06/2002 |
---|---|
Fund Manager | Simon Fan |
TER | 0.80 (31-Aug-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | £500 |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.09 |
You are here: research